Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04807075 · ClinicalTrials.gov registry record
A Wearable, Battery-free Screening System for SARS-CoV-2, the Virus Causing COVID-19 Infection
A clinical trial, sponsored by University of Nebraska.
- Terminated
- Registry status
- 1
- Enrollment target
NCT04807075: Clinical Trial study, sponsored by University of Nebraska.
NCT04807075 is a clinical trial that was terminated before completion, run by University of Nebraska. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04807075 was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The corona virus disease (COVID) pandemic has highlighted the importance of rapid, readily available screeners and diagnostics to identify infected individuals. Recent studies have demonstrated that portable electronic nose sensing devices can detect volatile organic compounds (VOCs). These compounds are end products of human metabolism or of enteric bacteria and are excreted through the skin or exhaled breath. Importantly, the sensing devices can be adapted into a wearable device providing continuous monitoring. Our goal is to develop a battery-free, electronic nose sensor to serve as a screener and detect VOC patterns associated to patients with symptomatic and asymptomatic COVID-19 without being invasive. To test the screening ability, devices will be worn by COVID-19 positive and negative patients hospitalized at Nebraska Medicine.
Primary Outcome
nose smell-print. This is recorded as a set of impedances, one from each sensor filament. This results in an 8-dimensional vector that will be recorded for each subject. The vectors will then be related to diagnostic category (SARS-CoV-2 positive vs. negative). This will be determined separately for each of the sensor devices.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2021-04-04 |
| Est. Completion | 2022-06-07 |
Why NCT04807075 stopped before completion
NCT04807075 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04807075 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04807075 about?
NCT04807075 is a clinical study titled "A Wearable, Battery-free Screening System for SARS-CoV-2, the Virus Causing COVID-19 Infection". The corona virus disease (COVID) pandemic has highlighted the importance of rapid, readily available screeners and diagnostics to identify infected individuals. Recent studies have demonstrated that portable electronic nose sensing devices can detect volatile organic compounds (VOCs). These compound...
What is the current status of trial NCT04807075?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2021-04-04. Estimated completion is 2022-06-07.
Who is sponsoring clinical trial NCT04807075?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI